Ovoca Gold PLC (OVXA) - Total Assets

Latest as of December 2023: €3.47 Million EUR ≈ $4.05 Million USD

Based on the latest financial reports, Ovoca Gold PLC (OVXA) holds total assets worth €3.47 Million EUR (≈ $4.05 Million USD) as of December 2023. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Ovoca Gold PLC (OVXA) shareholders funds for net asset value and shareholders' equity analysis.

Ovoca Gold PLC - Total Assets Trend (1987–2023)

This chart illustrates how Ovoca Gold PLC's total assets have evolved over time, based on quarterly financial data.

Ovoca Gold PLC - Asset Composition Analysis

Current Asset Composition (December 2023)

Ovoca Gold PLC's total assets of €3.47 Million consist of 100.0% current assets and 0.0% non-current assets.

Asset Category Amount (EUR) % of Total Assets
Cash & Equivalents €0.00 96.2%
Accounts Receivable €0.00 0.0%
Inventory €0.00 0.0%
Property, Plant & Equipment €0.00 0.0%
Intangible Assets €0.00 0.0%
Goodwill €0.00 0.0%

Asset Composition Trend (1987–2023)

This chart illustrates how Ovoca Gold PLC's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of Ovoca Gold PLC.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Ovoca Gold PLC's current assets represent 100.0% of total assets in 2023, an increase from 45.7% in 1987.
  • Cash Position: Cash and equivalents constituted 96.2% of total assets in 2023, up from 43.3% in 1987.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 1987.
  • Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.

Ovoca Gold PLC Competitors by Total Assets

Key competitors of Ovoca Gold PLC based on total assets are shown below.

Company Country Total Assets
Allakos Inc
NASDAQ:ALLK
USA $59.55 Million
Halozyme Therapeutics Inc
NASDAQ:HALO
USA $2.22 Billion
Hebei Changshan Biochem Pharma
SHE:300255
China CN¥4.66 Billion
Ligand Pharmaceuticals Incorporated
NASDAQ:LGND
USA $1.53 Billion
Arcutis Biotherapeutics Inc
NASDAQ:ARQT
USA $460.00 Million
Youcare Pharmaceutical Group Co. Ltd. A
SHG:688658
China CN¥5.19 Billion
MoonLake Immunotherapeutics
NASDAQ:MLTX
USA $424.43 Million
Chengdu Kanghua Biological Products
SHE:300841
China CN¥3.94 Billion

Ovoca Gold PLC - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 3.59 2.81 2.28
Quick Ratio 3.59 2.79 2.12
Cash Ratio 0.00 0.00 0.00
Working Capital €2.50 Million €3.21 Million €1.50 Million

Ovoca Gold PLC - Advanced Valuation Insights

This section examines the relationship between Ovoca Gold PLC's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 0.38
Latest Market Cap to Assets Ratio 0.25
Asset Growth Rate (YoY) -63.1%
Total Assets €3.47 Million
Market Capitalization $856.42K USD

Valuation Analysis

Below Book Valuation: The market values Ovoca Gold PLC's assets below their book value (0.25x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Ovoca Gold PLC's assets decreased by 63.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Ovoca Gold PLC (1987–2023)

The table below shows the annual total assets of Ovoca Gold PLC from 1987 to 2023.

Year Total Assets Change
2023-12-31 €3.47 Million
≈ $4.05 Million
-63.13%
2022-12-31 €9.40 Million
≈ $11.00 Million
-36.33%
2021-12-31 €14.77 Million
≈ $17.27 Million
-22.41%
2020-12-31 €19.04 Million
≈ $22.26 Million
-21.53%
2019-12-31 €24.26 Million
≈ $28.37 Million
+11.29%
2018-12-31 €21.80 Million
≈ $25.49 Million
-2.89%
2017-12-31 €22.45 Million
≈ $26.25 Million
-5.23%
2016-12-31 €23.69 Million
≈ $27.69 Million
+9.06%
2015-12-31 €21.72 Million
≈ $25.39 Million
-4.56%
2014-12-31 €22.76 Million
≈ $26.61 Million
-19.96%
2013-12-31 €28.43 Million
≈ $33.24 Million
-52.90%
2012-12-31 €60.37 Million
≈ $70.58 Million
-4.60%
2011-12-31 €63.28 Million
≈ $73.98 Million
-9.58%
2010-12-31 €69.98 Million
≈ $81.82 Million
+45.01%
2009-12-31 €48.26 Million
≈ $56.42 Million
+21.97%
2008-12-31 €39.57 Million
≈ $46.26 Million
-16.26%
2007-12-31 €47.25 Million
≈ $55.24 Million
+48.81%
2006-12-31 €31.75 Million
≈ $37.12 Million
+184.68%
2005-12-31 €11.15 Million
≈ $13.04 Million
+140.99%
2004-12-31 €4.63 Million
≈ $5.41 Million
-0.34%
2003-12-31 €4.64 Million
≈ $5.43 Million
+36.79%
2002-12-31 €3.40 Million
≈ $3.97 Million
-4.96%
2001-12-31 €3.57 Million
≈ $4.18 Million
+6.75%
2000-12-31 €3.35 Million
≈ $3.91 Million
-3.91%
1999-12-31 €3.48 Million
≈ $4.07 Million
-1.78%
1998-12-31 €3.54 Million
≈ $4.14 Million
+40.90%
1997-12-31 €2.52 Million
≈ $2.94 Million
+19.13%
1996-12-31 €2.11 Million
≈ $2.47 Million
-12.15%
1995-12-31 €2.40 Million
≈ $2.81 Million
+14.04%
1994-12-31 €2.11 Million
≈ $2.46 Million
-1.31%
1993-12-31 €2.14 Million
≈ $2.50 Million
+63.43%
1992-12-31 €1.31 Million
≈ $1.53 Million
+5.57%
1991-12-31 €1.24 Million
≈ $1.45 Million
-31.30%
1990-12-31 €1.80 Million
≈ $2.11 Million
-3.64%
1989-12-31 €1.87 Million
≈ $2.19 Million
+77.76%
1988-12-31 €1.05 Million
≈ $1.23 Million
+59.88%
1987-12-31 €658.00K
≈ $769.27K
--

About Ovoca Gold PLC

IR:OVXA Ireland Biotechnology
Market Cap
$1.00 Million
€856.42K EUR
Market Cap Rank
#30493 Global
#23 in Ireland
Share Price
€0.01
Change (1 day)
+0.00%
52-Week Range
€0.01 - €0.01
All Time High
€0.25
About

Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the development and commercialization of novel product candidates for women health. It's lead product is BP-101, a medicinal treatment for premenopausal women with hypoactive sexual desire disorder. The company was formerly known as Ovoca Gold plc and changed its name to Ovoca Bio plc in July 2018. Ovoca Bio plc was incorporate… Read more